Bottom line
Is HCPSX a good fund? The bottom line
HCPSX is a share class of Health Care Ultrasector Profund, an actively managed health care sector mutual fund from ProShares.
Its expense ratio is 2.76% — about $276 a year on every $10,000 invested, more expensive than 99% of health care sector funds we track.
It returned −2.4% over one year, +5.3% a year over five years, +8.1% a year over ten (as of Dec 31, 2024, per its prospectus).
With $12.1 million in net assets and 69 holdings, its largest position is Eli Lilly & Company (11.8%) and the top 10 make up 57.2% of the portfolio.
The closest lower-cost alternative we found is XLV (0.08%, 70% top-holdings overlap).
What to watch
- Expensive for its category (2.76%)
- Concentrated: top 10 holdings are 57.2% of assets
- 12b-1 marketing fee of 1% a year
- Small fund ($12.1 million) — small funds are likelier to close
Updated Nov 19, 2026
What HCPSX invests in
Health Care UltraSector ProFund (the Fund) seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) of the daily performance of the S&P Health Care Select Sector Index (the Index).
The Fund invests in financial instruments that ProFund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is designed to measure the performance of health care companies included in the S&P 500 Index. The S&P 500 Index is designed to measure the performance of 500 of the largest companies listed and domiciled in the U.S. The Index includes health care companies in the following industries according to the Global Industry Classification Standard (GICS): health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. These companies are then weighted based on market capitalization. The Indexs composition and the assigned weights are reevaluated every September with additional weight adjustments in March, June, and December. The Index is…
From the fund's prospectus (filed Nov 25, 2025).
HCPSX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HCPSX | −2.4% | +5.3% | +8.1% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2024
What HCPSX costs
On a $10,000 investment, HCPSX's 2.76% expense ratio costs about $276 a year. The prospectus estimates $3,090 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
HCPSX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Company | 11.83% |
| 2 | Johnson & Johnson | 8.03% |
| 3 | N/a | 6.45% |
| 4 | Abbvie Inc | 5.77% |
| 5 | N/a | 4.97% |
| 6 | Unitedhealth Group Inc | 4.90% |
| 7 | Merck & Company Inc | 4.19% |
| 8 | N/a | 3.96% |
| 9 | N/a | 3.96% |
| 10 | N/a | 3.11% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 57.2% of the fund. See all top 25 holdings and asset mix →
Alternatives to HCPSX
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 70% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 70% | Compare |
| Vanguard | VHT Vanguard Health Care Index Fund | 0.09% | 72% | Compare |
| iShares | IXJ iShares Global Healthcare ETF | 0.38% | 72% | Compare |
| Schwab | SWHFX Schwab Health Care Fund | 0.8% | 61% | Compare |
| T. Rowe Price | PRHSX T. Rowe Price Health Sciences Fund, Inc. | 0.83% | 65% | Compare |